Mauser-Bunschoten E.

patient study von willebrand disease disease hemophilia liver willebrand score treatment brosi women hepatitis c hr-qol result vwd patients children fi brosis haemophilia center level netherland health liver fi brosis population hepatitis fviii table disorder lsm results university type 3 vwd difference arthropathy factor severity blood quality questionnaire biopsy measurement menorrhagia lsm 1 number scale activity signi thromb prophylaxi phenotype change hemophilia patients symptom haemost infection effect von willebrand factor thrombosis quartile type 1 vwd fi brinolysis haemostasi fviii levels ficant hr-qol scores group plasma summary impact cirrhosis school children leiden university limitation lsm 2 bleed stiffness domain employment component summary parent health perceptions